---
id: FC-050
type: Flashcard
created: 2025-08-08 09:58:53.816588
tags:
- Flashcard
- question
- endocrine
topic: endocrine
answer: C
related_articles:
- title: Semaglutide (Wegovy) for the Treatment of Obesity.
  path: 2023/2023-01-semaglutide-wegovy-for-the-treatment-of-obesity.md
  similarity: 0.462
  link: '[[2023/2023-01-semaglutide-wegovy-for-the-treatment-of-obesity|Semaglutide
    (Wegovy) for the Treatment of Obesity.]]'
- title: 'Gallstone Disease: Common Questions and Answers.'
  path: 2024/2024-06-gallstone-disease-common-questions-and-answers.md
  similarity: 0.438
  link: '[[2024/2024-06-gallstone-disease-common-questions-and-answers|Gallstone Disease:
    Common Questions and Answers.]]'
- title: Artificial Intelligence Scribes Shape Health Care Delivery.
  path: 2025/2025-04-artificial-intelligence-scribes-shape-health-care-delivery.md
  similarity: 0.429
  link: '[[2025/2025-04-artificial-intelligence-scribes-shape-health-care-delivery|Artificial
    Intelligence Scribes Shape Health Care Delivery.]]'
- title: 'Thrombocytopenia: Evaluation and Management.'
  path: 2022/2022-09-thrombocytopenia-evaluation-and-management.md
  similarity: 0.4
  link: '[[2022/2022-09-thrombocytopenia-evaluation-and-management|Thrombocytopenia:
    Evaluation and Management.]]'
- title: 'Osteoporosis: Common Questions and Answers.'
  path: 2023/2023-03-osteoporosis-common-questions-and-answers.md
  similarity: 0.385
  link: '[[2023/2023-03-osteoporosis-common-questions-and-answers|Osteoporosis: Common
    Questions and Answers.]]'
topics:
- Emergency Medicine
- Endocrinology
- Gastroenterology
- Nephrology
---

# Flashcard FC-050

## Question

which one of the followingstatementsaboutmetabolicdysfunction-associatedsteatoticliverdisease (MASLD)is correct? Anaspartatetransaminase(AST)toalaninetransaminase(ALT)ratiogreaterthan0.8 rulesout MASLD. Ultrasonographyisthemostaccuratemethodtodifferentiatebetween MASLDandalcoholicliver disease. Weightlossofmorethan10 inpatientswith MASLDisassociatedwithimprovementinfibrosis. Glucagon-likepeptide-1 receptoragonistshavebeenapprovedbythe USFoodand Drug Administrationfortreatmentof MASLD. @ Back

## Answer

**C**

## Explanation

Weightlossof3 Yto5 isassociatedwithanimprovementinsteatosis,andweightlossofmorethan 10 isassociatedwithanimprovementinfibrosis. Althoughpatientswith MASLDtypicallyhavean ASTto ALTratiolessthan0.8,noserologictestcan diagnose MASLD. Ultrasonographycan beusedtoidentifythepresenceofafattyliver,butitcannot distinguishbetween MASLDandalcoholicliverdisease. Certainmedicationclasses,includingglucagon- likepeptide-1 receptoragonistsandsodium-glucosecotransporter-2 inhibitors,can beusedforoff-label treatmentof MASLD. e

## References

- AAFPQuestion Bank-Pythonsimplecapture.

